Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance

Turpin, S, Lancaster, G, Darby, I, Febbraio, M and Watt, M 2006, 'Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance', American Journal of Physiology: Endocrinology and Metabolism, vol. 291, pp. E1341-E1350.


Document type: Journal Article
Collection: Journal Articles

Title Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance
Author(s) Turpin, S
Lancaster, G
Darby, I
Febbraio, M
Watt, M
Year 2006
Journal name American Journal of Physiology: Endocrinology and Metabolism
Volume number 291
Start page E1341
End page E1350
Publisher American Physiological Society
Abstract Fatty acid-induced apoptosis occurs in pancreatic -cells and contributes to the metabolic syndrome. Skeletal muscle insulin resistance is mediated by fatty acid oversupply, which also contributes to the metabolic syndrome. Therefore, we examined whether fatty acids induce apoptosis in skeletal muscle myotubes, the proapoptotic signaling involved, and the effects on insulin sensitivity. Exposure of L6 myotubes to palmitate induced apoptosis, as demonstrated by increased caspase-3 activation, phosphatidylserine exposure on the plasma membrane, and terminal deoxynucleotide transferase dUTP nick end labeling and DNA laddering, both markers of DNA fragmentation. Ceramide content was concomitantly increased, indicating a potential role for ceramides in palmitate-induced apoptosis. Supporting this notion, reducing stearoyl-CoA desaturase-1 (SCD-1) protein content with short interfering RNA resulted in ceramide accumulation and was associated with increased apoptosis in the absence of palmitate. Furthermore, the membrane-permeable C2-ceramide enhanced apoptosis in myotubes, whereas the ceramide synthase inhibitor, fumonisin B1, abrogated the proapoptotic effects of palmitate. Insulin-stimulated glucose uptake was inhibited by palmitate treatment, whereas the addition of effector caspase inhibitors [Ac-DEVD-aldehyde (DEVD-CHO), Z-DQMD-FMK] independently restored >80% of the insulin-stimulated glucose uptake. These effects were observed independently from changes in the protein content of insulin signaling proteins, suggesting that proteosomal degradation is not involved in this process. We conclude that lipoapoptosis occurs in skeletal muscle myotubes, at least partially via de novo ceramide accumulation, and that inhibiting downstream apoptotic signaling improves glucose uptake in vitro.
Subject Endocrinology
DOI - identifier 10.1152/ajpendo.00095.2006
Copyright notice © 2006 American Physiological Society
ISSN 0193-1849
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 96 times in Scopus Article | Citations
Altmetric details:
Access Statistics: 208 Abstract Views  -  Detailed Statistics
Created: Wed, 18 Feb 2009, 09:53:18 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us